Post-effective amendment to a registration statement that is not immediately effective upon filing

Significant Accounting Policies (Tables)

v3.23.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Significant Accounting Policies  
Summary of sources (by product type) from which the Company's revenues are derived

Successor

Predecessor

Year Ended

December 3, 2021

January 1, 2021

December 31,

through December 31,

through December 2,

Revenue Type

    

2022

    

% of Total

    

2021

    

% of Total

  

  

2021

    

% of Total

    

Capitated revenue

$

1,034,800

99

%

$

57,224

97

$

567,735

98

Other patient service revenue:

Clinical fees & insurance revenue

 

6,158

0

%

751

 

2

4,318

 

1

Shared risk revenue

 

351

0

%

181

 

0

602

 

0

Care coordination / management fees

7,924

1

%

600

1

5,880

1

Incentive fees

 

238

0

%

6

 

0

67

 

0

Total other patient service revenue

 

14,671

1

%

1,538

 

3

10,867

 

2

Total revenue

$

1,049,471

100

%

$

58,762

 

100

$

578,602

 

100

Summary of estimated useful lives applicable to PP&E

Classification

    

Depreciation Cycle

Leasehold improvements (cycle: lease term)

 

1 to 10 Years

Furniture and fixtures

 

7 Years

Computer equipment

 

3 Years

Medical equipment

 

7 Years

Software

 

3 Years